Angio Lab
Latest round
- Series C
Last raised
- Sep 2016
Total raised
- $6.8M
Investors
- 4
About Angio Lab
Based in Daejeon, South Korea, and founded in 1999, AngioLab, Inc. operates as a bio-venture company that developed therapies for angiogenesis-related diseases by inhibiting angiogenesis. The firm operates as a biotechnological company with specialized technologies to develop and offer new therapies to treat various diseases such as cancer growth and metastasis, abdominal obesity, eye diseases, psoriasis, and arthritis based on angiogenesis inhibition-related candidates. The company also offers treatment for abdominal obesity, treatment of retinopathy such as macular degeneration, periodontal disease treatment, and anti-tank drugs.
Who invested in Angio Lab
4 investors across 1 round
See all investors in Angio Lab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Sep 20, 2016
Amount
$6.8M
Investors
Questions about Angio Lab
Who invested in Angio Lab?
Angio Lab has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Angio Lab raised?
Angio Lab has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Angio Lab last raise money?
Angio Lab's most recent round on record is a Series C, in Sep 2016.
What does Angio Lab do?
Based in Daejeon, South Korea, and founded in 1999, AngioLab, Inc.
Where is Angio Lab headquartered?
Angio Lab is headquartered in Daejeon, South Korea.
Which VCs invest in companies like Angio Lab?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Angio Lab's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Angio Lab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.